ifosfamide ( ifos ) 5 g/m2 and its parent analog cyclophosphamide ( cyclo ) 1.5 g/m2 were studied in a randomized phase ii study , accruing 171 patients with advanced soft tissue sarcoma .
C0020823
ifosfamide
C1261473
soft tissue sarcoma